The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Insights from transgenic mouse models of ERBB2-induced breast cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760
Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., Ullrich, A., et al. (1989) · Science · doi:10.1126/science.2470152 · Cited by 6,816
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628
Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer
Romond, E. H., Perez, E. A., Bryant, J., Suman, V. J., Geyer, C. E., Davidson, N. E., Tan-Chiu, E., Martino, S., Paik, S., Kaufman, P. A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052122 · Cited by 5,356
Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
Piccart-Gebhart, M. J., Procter, M., Leyland-Jones, B., Goldhirsch, A., Untch, M., Smith, I., Gianni, L., Baselga, J., Bell, R., Jackisch, C., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052306 · Cited by 5,084
Generation of a functional mammary gland from a single stem cell
Shackleton, M., Vaillant, F., Simpson, K. J., Stingl, J., Smyth, G. K., Asselin-Labat, M.-L., Wu, L., Lindeman, G. J., & Visvader, J. E. (2006) · Nature · doi:10.1038/nature04372 · Cited by 2,005
Cancer stem cells: an old idea–a paradigm shift
Wicha, M. S., Liu, S., & Dontu, G. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3153 · Cited by 1,378
Genomic and transcriptional aberrations linked to breast cancer pathophysiologies
Chin, K., DeVries, S., Fridlyand, J., Spellman, P. T., Roydasgupta, R., Kuo, W.-L., Lapuk, A., Neve, R. M., Qian, Z., Ryder, T., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.009 · Cited by 1,317
Guy, C. T., Webster, M. A., Schaller, M., Parsons, T. J., Cardiff, R. D., & Muller, W. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10578 · Cited by 1,193
Self-citationThe neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen
Schechter, A. L., Stern, D. F., Vaidyanathan, L., Decker, S. J., Drebin, J. A., Greene, M. I., & Weinberg, R. A. (1984) · Nature · doi:10.1038/312513a0 · Cited by 1,175
Muller, W. J., Sinn, E., Pattengale, P. K., Wallace, R., & Leder, P. (1988) · Cell · doi:10.1016/0092-8674(88)90184-5 · Cited by 1,165
Self-citationc-erbB-2 Expression and Response to Adjuvant Therapy in Women with Node-Positive Early Breast Cancer
Muss, H. B., Thor, A. D., Berry, D. A., Kute, T., Liu, E. T., Koerner, F., Cirrincione, C. T., Budman, D. R., Wood, W. C., Barcos, M., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199405053301802 · Cited by 961
Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes
Stewart, T. A., Pattengale, P. K., & Leder, P. (1984) · Cell · doi:10.1016/0092-8674(84)90257-5 · Cited by 899
Sinn, E., Muller, W., Pattengale, P., Tepler, I., Wallace, R., & Leder, P. (1987) · Cell · doi:10.1016/0092-8674(87)90449-1 · Cited by 792
Self-citationTransforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts
Shih, C., Padhy, L. C., Murray, M., & Weinberg, R. A. (1981) · Nature · doi:10.1038/290261a0 · Cited by 791
The transcriptional repressor Snail promotes mammary tumor recurrence
Moody, S. E., Perez, D., Pan, T.-C., Sarkisian, C. J., Portocarrero, C. P., Sterner, C. J., Notorfrancesco, K. L., Cardiff, R. D., & Chodosh, L. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.07.009 · Cited by 750
Self-citationGarrett, T. P. J., McKern, N. M., Lou, M., Elleman, T. C., Adams, T. E., Lovrecz, G. O., Kofler, M., Jorissen, R. N., Nice, E. C., Burgess, A. W., et al. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00048-0 · Cited by 613
Li, Y., Welm, B., Podsypanina, K., Huang, S., Chamorro, M., Zhang, X., Rowlands, T., Egeblad, M., Cowin, P., Werb, Z., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2136825100 · Cited by 521
HER2 and Responsiveness of Breast Cancer to Adjuvant Chemotherapy
Pritchard, K. I., Shepherd, L. E., O'Malley, F. P., Andrulis, I. L., Tu, D., Bramwell, V. H., & Levine, M. N. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054504 · Cited by 509
Robert, N., Leyland-Jones, B., Asmar, L., Belt, R., Ilegbodu, D., Loesch, D., Raju, R., Valentine, E., Sayre, R., Cobleigh, M., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.1764 · Cited by 479
Rodríguez-Manzaneque, J. C., Lane, T. F., Ortega, M. A., Hynes, R. O., Lawler, J., & Iruela-Arispe, M. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171460498 · Cited by 473
β4 Integrin Amplifies ErbB2 Signaling to Promote Mammary Tumorigenesis
Guo, W., Pylayeva, Y., Pepe, A., Yoshioka, T., Muller, W. J., Inghirami, G., & Giancotti, F. G. (2006) · Cell · doi:10.1016/j.cell.2006.05.047 · Cited by 455
Self-citationHigh frequency of hypermethylation at the 14-3-3 σ locus leads to gene silencing in breast cancer
Ferguson, A. T., Evron, E., Umbricht, C. B., Pandita, T. K., Chan, T. A., Hermeking, H., Marks, J. R., Lambers, A. R., Futreal, P. A., Stampfer, M. R., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100566997 · Cited by 444
Siegel, P. M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.8.2149 · Cited by 442
Hermeking, H. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1230 · Cited by 437
Siegel, P. M., Shu, W., Cardiff, R. D., Muller, W. J., & Massagué, J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932636100 · Cited by 429
Self-citationBulavin, D. V., Phillips, C., Nannenga, B., Timofeev, O., Donehower, L. A., Anderson, C. W., Appella, E., & Fornace, A. J. (2004) · Nature Genetics · doi:10.1038/ng1317 · Cited by 409
Akt Blocks Breast Cancer Cell Motility and Invasion through the Transcription Factor NFAT
Yoeli-Lerner, M., Yiu, G. K., Rabinovitz, I., Erhardt, P., Jauliac, S., & Toker, A. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.10.033 · Cited by 407
Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene
Bouchard, L., Lamarre, L., Tremblay, P. J., & Jolicoeur, P. (1989) · Cell · doi:10.1016/0092-8674(89)90331-0 · Cited by 393
Moody, S. E., Sarkisian, C. J., Hahn, K. T., Gunther, E. J., Pickup, S., Dugan, K. D., Innocent, N., Cardiff, R. D., Schnall, M. D., & Chodosh, L. A. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00212-x · Cited by 345
Self-citationCyclin D1-dependent kinase activity in murine development and mammary tumorigenesis
Landis, M. W., Pawlyk, B. S., Li, T., Sicinski, P., & Hinds, P. W. (2006) · Cancer Cell · doi:10.1016/j.ccr.2005.12.019 · Cited by 329
Julien, S. G., Dubé, N., Read, M., Penney, J., Paquet, M., Han, Y., Kennedy, B. P., Muller, W. J., & Tremblay, M. L. (2007) · Nature Genetics · doi:10.1038/ng1963 · Cited by 316
Self-citationHypermethylation of 14-3-3 σ (stratifin) is an early event in breast cancer
Umbricht, C. B., Evron, E., Gabrielson, E., Ferguson, A. T., Marks, J., & Sukumar, S. (2001) · Oncogene · doi:10.1038/sj.onc.1204438 · Cited by 291
Wagner, K.-U., Ward, T., Davis, B., Wiseman, R., & Hennighausen, L. (2001) · Transgenic Research · doi:10.1023/a:1013063514007 · Cited by 283
The Comparative Pathology of Human and Mouse Mammary Glands
Cardiff, R. D., & Wellings, S. R. (1999) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1018712905244 · Cited by 255
Self-citationHutchinson, J. N., Jin, J., Cardiff, R. D., Woodgett, J. R., & Muller, W. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3465 · Cited by 251
Self-citationStein, D., Wu, J., Fuqua, S. A., Roonprapunt, C., Yajnik, V., D'Eustachio, P., Moskow, J. J., Buchberg, A. M., Osborne, C. K., & Margolis, B. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06386.x · Cited by 249
Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis
Andrechek, E. R., Hardy, W. R., Siegel, P. M., Rudnicki, M. A., Cardiff, R. D., & Muller, W. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3444 · Cited by 230
Howe, L. R., Subbaramaiah, K., Patel, J. A., Masferrer, J. L., Deora, A., Hudis, C. A., Thaler, H. T., Muller, W. J., Du, B., Brown, A. M. C., et al. (2002) · PubMed · Cited by 219
Self-citationNovel activating mutations in the neu proto-oncogene involved in induction of mammary tumors.
Siegel, P. M., Dankort, D. L., Hardy, W. R., & Muller, W. J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.11.7068 · Cited by 213
Self-citationModeling breast cancer in vivo and ex vivo reveals an essential role of Pin1 in tumorigenesis
Wulf, G., Garg, P., Liou, Y., Iglehart, D., & Lu, K. P. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600323 · Cited by 203
Muraoka, R. S., Koh, Y., Roebuck, L. R., Sanders, M. E., Brantley-Sieders, D., Gorska, A. E., Moses, H. L., & Arteaga, C. L. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.23.8691-8703.2003 · Cited by 191
Expression of c-erbB3 protein in primary breast carcinomas
Naidu, R., Yadav, M., Nair, S., & Kutty, M. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.689 · Cited by 190
Rosner, A., Miyoshi, K., Landesman-Bollag, E., Xu, X., Seldin, D. C., Moser, A. R., MacLeod, C. L., Shyamala, G., Gillgrass, A. E., & Cardiff, R. D. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64269-1 · Cited by 168
Self-citationHowe, L. R., Chang, S.-H., Tolle, K. C., Dillon, R., Young, L. J. T., Cardiff, R. D., Newman, R. A., Yang, P., Thaler, H. T., Muller, W. J., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1524 · Cited by 165
Self-citationDankort, D., Maslikowski, B., Warner, N., Kanno, N., Kim, H., Wang, Z., Moran, M. F., Oshima, R. G., Cardiff, R. D., & Muller, W. J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.5.1540-1551.2001 · Cited by 163
Self-citationProteomic analysis reveals that 14-3-3sigma is down-regulated in human breast cancer cells.
Vercoutter‐Edouart, A., Lemoine, J., Bourhis, X. L., Hornez, L., Boilly, B., Nurcombe, V., Révillion-Carette, F., Peyrat, J., & Hondermarck, H. (2001) · PubMed · Cited by 157
Dankort, D. L., Wang, Z., Blackmore, V., Moran, M. F., & Muller, W. J. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5410 · Cited by 157
Self-citationActivated neu Induces Rapid Tumor Progression
Guy, C. T., Cardiff, R. D., & Muller, W. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.13.7673 · Cited by 145
Self-citationA novel splice variant ofHER2 with increased transformation activity
Kwong, K. Y., & Hung, M. (1998) · Molecular Carcinogenesis · Cited by 139
Muraoka-Cook, R. S., Shin, I., Yi, J. Y., Easterly, E., Barcellos‐Hoff, M. H., Yingling, J. M., Zent, R., & Arteaga, C. L. (2005) · Oncogene · doi:10.1038/sj.onc.1208964 · Cited by 139
Cabodi, S., Tinnirello, A. A., Stefano, P. D., Bisarò, B., Ambrosino, E., Castellano, I., Sapino, A., Arisio, R., Cavallo, F., Forni, G., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2909 · Cited by 136
Human ErbB-2 (Her-2) Transgenic Mice: A Model System for Testing Her-2 Based Vaccines
Piechocki, M. P., Ho, Y.-S., Pilon, S. A., & Wei, W. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.11.5787 · Cited by 127
Stem Cells in Mammary Development and Carcinogenesis: Implications for Prevention and Treatment
Dontu, G., Liu, S., & Wicha, M. S. (2005) · Stem Cell Reviews and Reports · doi:10.1385/scr:1:3:207 · Cited by 126
Finkle, D., Quan, Z. R., Asghari, V., Kloss, J., Ghaboosi, N., Mai, E., Wong, W. L., Hollingshead, P., Schwall, R., Koeppen, H., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0448 · Cited by 125
Prevention of mammary tumors with a chimeric HER-2 B-cell epitope peptide vaccine.
Dakappagari, N. K., Douglas, D. B., Triozzi, P. L., Stevens, V. C., & Kaumaya, P. T. P. (2000) · PubMed · Cited by 110
Cyclin-Dependent Kinase 4 Expression Is Essential for Neu-Induced Breast Tumorigenesis
Reddy, H. K. D. L., Mettus, R. V., Rane, S. G., Graña, X., Litvin, J., & Reddy, E. P. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2639 · Cited by 108
neu/ERBB2 Cooperates with p53-172H during Mammary Tumorigenesis in Transgenic Mice
Li, B., Rosen, J. M., McMenamin-Balano, J., Muller, W. J., & Perkins, A. S. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.6.3155 · Cited by 106
Self-citationOverview of treatment results with trastuzumab (Herceptin) in metastatic breast cancer
Hortobágyi, G. N. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90108-3 · Cited by 105
Siegel, P. M., & Muller, W. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.8878 · Cited by 104
Self-citationThe MMTV LTR Promoter is Induced by Progesterone and Dihydrotestosterone but not by Estrogen
Otten, A., Sanders, M. M., & McKnight, G. S. (1988) · Molecular Endocrinology · doi:10.1210/mend-2-2-143 · Cited by 102
Antitumor Activity of Rapamycin in a Transgenic Mouse Model of ErbB2-Dependent Human Breast Cancer
Liu, M., Howes, A. L., Lesperance, J., Stallcup, W. B., Hauser, C. A., Kadoya, K., Oshima, R. G., & Abraham, R. T. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4589 · Cited by 97
Multiple ErbB-2/Neu Phosphorylation Sites Mediate Transformation through Distinct Effector Proteins
Dankort, D. L., Jeyabalan, N., Jones, N., Dumont, D., & Muller, W. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106239200 · Cited by 96
Self-citationMontagna, C., Andrechek, E. R., Padilla‐Nash, H. M., Muller, W. J., & Ried, T. (2002) · Oncogene · doi:10.1038/sj.onc.1205146 · Cited by 94
Self-citationSakai, Y., Morrison, B. J., Burke, J. D., Park, J.-M., Terabe, M., Janik, J. E., Forni, G., Berzofsky, J. A., & Morris, J. C. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3442 · Cited by 94
Kauraniemi, P., Kuukasjärvi, T., Sauter, G., & Kallioniemi, A. H. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63556-0 · Cited by 91
A DNA vaccine targeting angiomotin inhibits angiogenesis and suppresses tumor growth
Holmgren, L., Ambrosino, E., Birot, O., Tullus, C., Veitonmäki, N., Levchenko, T., Carlson, L.-M., Musiani, P., Iezzi, M., Curcio, C., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603110103 · Cited by 88
Stöcklin, E., Botteri, F. M., & Groner, B. (1993) · The Journal of Cell Biology · doi:10.1083/jcb.122.1.199 · Cited by 88
de Candia, P., Solit, D. B., Giri, D. D., Brogi, E., Siegel, P. M., Olshen, A. B., Muller, W. J., Rosen, N. X., & Benezra, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2031337100 · Cited by 86
Self-citationTransgenic mouse models of mammary tumorigenesis.
Cardiff, R. D., & Muller, W. (1993) · PubMed · Cited by 83
Self-citationMano, M. S., Rosa, D. D., de Azambuja, E., Ismael, G., & Durbecq, V. (2006) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2006.10.001 · Cited by 76
Pegram, M. D., & Ngo, D. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.05.003 · Cited by 65
Andrechek, E. R., Laing, M. A., Girgis-Gabardo, A., Siegel, P. M., Cardiff, R. D., & Muller, W. J. (2003) · PubMed · Cited by 65
Self-citationDang, C. T., Dannenberg, A. J., Subbaramaiah, K., Dickler, M. N., Moasser, M. M., Seidman, A. D., D’Andrea, G. M., Theodoulou, M., Panageas, K. S., Norton, L., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0463 · Cited by 62
Bowe, D. B., Kenney, N. J., Adereth, Y., & Maroulakou, I. G. (2002) · Oncogene · doi:10.1038/sj.onc.1205025 · Cited by 61
Hodgson, J. G., Malek, T. B., Bornstein, S., Hariono, S., Ginzinger, D. G., Muller, W. J., & Gray, J. W. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0755 · Cited by 52
Self-citationAngiogenic Acceleration of Neu Induced Mammary Tumor Progression and Metastasis
Oshima, R. G., Lesperance, J., Munoz-Ritchie, V. G., Hebbard, L., Ranscht, B., Sharan, N., Muller, W. J., Hauser, C. A., & Cardiff, R. D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1944 · Cited by 51
Self-citationHulit, J., Lee, R. J., Li, Z., Wang, C., Katiyar, S., Yang, J., Quong, A. A., Wu, K., Albanese, C., Russell, R. G., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0149 · Cited by 41
Self-citationCanney, P. A., Machin, M. A., & Curto, J. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.08.014 · Cited by 38
Chan, R., Muller, W. J., & Siegel, P. M. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb08722.x · Cited by 27
Self-citationNagai, H., Kinoshita, T., Suzuki, H., Hatano, S., Murate, T., & Saito, H. (1999) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199907)25:3<251::aid-gcc7>3.0.co;2-3 · Cited by 22
Cited by
Novel anticancer targets: revisiting ERBB2 and discovering ERBB3
Baselga, J., & Swain, S. M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2656 · Cited by 1,142
The epidermal growth factor receptor family: Biology driving targeted therapeutics
Wieduwilt, M. J., & Moasser, M. M. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7440-8 · Cited by 751
Modelling breast cancer: one size does not fit all
Vargo-Gogola, T., & Rosen, J. M. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2193 · Cited by 679
Nanoparticles and targeted drug delivery in cancer therapy
Bahrami, B., Hojjat-Farsangi, M., Mohammadi, H., Anvari, E., Ghalamfarsa, G., Yousefi, M., & Jadidi-Niaragh, F. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.07.015 · Cited by 510
HER2 expression status in diverse cancers: review of results from 37,992 patients
Yan, M., Schwaederle, M., Arguello, D., Millis, S. Z., Gatalica, Z., & Kurzrock, R. (2015) · Cancer and Metastasis Reviews · doi:10.1007/s10555-015-9552-6 · Cited by 483
Metadata
- Authors
- Ursini-Siegel, J., Schade, B., Cardiff, R. D., & Muller, W. J.
- Venue
- Nature Reviews Cancer
- Published
- 2007-04-19
- Volume
- 7
- Issue
- 5
- Pages
- 389-397
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2086606630
- Cited by
- 269
- References
- 81
- FWCI
- 1.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.